Tibial Lead Levels and Erythropoiesis Stimulating Agent Dosing among 75 Patients with End-Stage Kidney Disease.

Environ Health Perspect

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Published: April 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057664PMC
http://dx.doi.org/10.1289/EHP14199DOI Listing

Publication Analysis

Top Keywords

tibial lead
4
lead levels
4
levels erythropoiesis
4
erythropoiesis stimulating
4
stimulating agent
4
agent dosing
4
dosing patients
4
patients end-stage
4
end-stage kidney
4
kidney disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!